Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1124-11-4

Post Buying Request

1124-11-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1124-11-4 Usage

Description

Different sources of media describe the Description of 1124-11-4 differently. You can refer to the following data:
1. Tetramethylpyrazine (TMP) is a kind of alkaloids identified in Ligusticum wallichii FRANCH. It has various kinds of medical applications. It has long been used in China for the treatment of cardiovascular problems. It also has antiinflammatory and analgesic effect. It can be used for the treatment of diabetic peripheral neuropathy. Through effectively penetrating across the blood-brain barrier, it can exert its neuroprotection function which is useful for the treatment of ischemic brain injury. Moreover, it can eliminate superoxide anion and decreases nitric oxide production in human polymorphonuclear leukocytes.
2. Ligustrazine is an alkaloid derived from chuanxiong (Ligusticum chuanxiong Hort; L. wallichii). Ligusticum wallichii Franchat (or Ligusticum chuanxiong Hort; L. wallichii), a member of the Umbelliferaceae family, is a Chinese medicinal herb that is a common constituent in polypharmaceutical herbal drugs. It has been widely used in Asian countries to increase coronary blood flow and systemic circulation and to relieve stasis.Ligusticum walliichi has the effects of promoting Qi and nourishing blood. Ligusticum walliichi, angelica, and peony were used as medicinal herbs, and thecommonly used Yangxue Siwu decoction was proposed for clinical practice. The combination of gypsum and Ligusticum walliichi can clear lung heat and eliminate cough and asthma. It is a common drug for clearing away heat and toxic substances and purging fire. The compatibility of Ligusticum walliichi and Radix Linderae can regulate the blood and Qi and treat women’s headaches and colds and retrograde and other related pains.Ligusticum walliichi is warm, acrid, and bitter. It can regulate the blood and conduct Qi, which is commonly used in oral administration. Ligusticum walliichi is used to treat apoplexy, headache, cold pain, the upper reaches of the wind, tears clogging of nose by cold, and so on. At present, the study of Chuanxiong in China and abroad has occurred at the molecular level .
3. 2,3,5,6-Tetramethylpyrazine is an alkaloid that has been found in L. wallichii and has diverse biological activities. It reduces kainate-induced increases in production of reactive oxygen species (ROS) and cytotoxicity in primary rat hippocampal neurons when used at a concentration of 5 μM. 2,3,5,6-Tetramethylpyrazine (0.1 mM) induces vasodilation in precontracted isolated and endothelium-denuded rat tail artery strips and reduces blood pressure in anesthetized rats. It decreases infarct volume, caspase-3 activation, and hypoxia-inducible factor-1α (HIF-1α) levels in a rat model of focal cerebral ischemia induced by middle cerebral artery occlusion (MCAO) when administered at a dose of 20 mg/kg.

Chemical Characteristic

White crystal or powder. With aroma of beef and heated lard and fermented soybean flavor. It smells chocolate flavor when diluted to 20mg/kg. Boiling point is 190℃. Melting point is between 84 and 86℃. Soluble in ethanol, most non-volatile oils and propylene glycol, slightly soluble in water. Natural products exist in guava, roast beef, cocoa, coffee, shrimp and so on.

Uses

Different sources of media describe the Uses of 1124-11-4 differently. You can refer to the following data:
1. Permissible edible flavors, mainly used to prepare meat, cocoa, peanut, nut, coffee, chocolate flavor and so on; For medicine production; Used as flavoring agents, sweeteners for alcoholic beverages, flavor and enriching supplement for cigarettes.
2. etramethylpyrazine is an anti-inflammatory compound isolated from the fermented food natto. Tetramethylpyrazine demonstrated in vivo nootropic activity in rats.
3. 2,3,5,6-Tetramethylpyrazine may be used as an analytical reference standard for the quantification of the analyte in Ephedrae herba and Ephedra sinica Stapf using different chromatography techniques.
4. Usually used in research and treatment of multiple disorders.

Preparation

Different sources of media describe the Preparation of 1124-11-4 differently. You can refer to the following data:
1. Butanedione monoxime generated by butanone and ethyl nitrite condensation is reduced and cyclized to produce methylpyrazine. The cyclization reaction product is subjected to steam distillation and the distillate is cooled,crystallized and filtered to generate crude tetramethylpyrazine which is refined with water recrystallization and activated carbon to decolor. Ethanol solution with 15% to 20% hydrogen chloride can be added into acetone to prepare hydrochloride salt. Condensed by 2,3-butanedione and 2,3-butanediamine.
2. From2,5-dimethylpyrazine by ring alkylationwithMeLi; also by condensation of 2,3-butanedionewith 2,3-butanediamine.

References

TH Tsai, CC Liang. International Journal of Pharmaceutics, 216. 1-2 (2001) WU, Zhi-youg, et al. Chinese Journal of Experimental Traditional Medical Formulae 14 (2012): 085. Ozaki, Yukihiro. Chemical and pharmaceutical bulletin 40.4 (1992): 954-956. Kao, Tsung-Kuei, et al. Neurochemistry international 48.3 (2006): 166-176. Zhang, Zhaohui, et al. Life sciences 72.22 (2003): 2465-2472.

Chemical Properties

Different sources of media describe the Chemical Properties of 1124-11-4 differently. You can refer to the following data:
1. white crystals or powder
2. 2,3,5,6-Tetramethylpyrazine has musty, fermented, coffee odor

Physical properties

Appearance: colorless needle crystal. Solubility: soluble in hot water, petroleum ether, chloroform, dilute hydrochloric acid, slightly soluble in ether, insoluble in cold water. Melting point: 77–80°C. Boiling point: 190°C. Flash point: 128– 130°C/200mm. Ligustrazine has a particular odor, moisture absorption, and sublimation.

Occurrence

Reported found in French fried potato, bell pepper, wheat bread, emmental cheese, Swiss cheese, Camembert cheese, Gruyere cheese, boiled and cooked beef, grilled and roasted beef, fried beef, cooked lamb and mutton, lamb and mutton liver, grilled and roasted uncured pork, beer, black tea, green tea. Also reported present in cocoa products, coffee, dairy products, oatmeal, galbanum oil, roasted peanuts, soybean, beans, mushroom, trassi, coriander seed, rice bran, trassi, sukiyaki, soy sauce, malt, licorice, dried bonito, wild rice, shrimp, crab, clam, scallop, filberts, rum, sake, wine, whiskey, burley tobacco and soy products.

History

Ligusticum walliichi has a long medicinal history in China and is used in the treatment of headache, promoting blood and Qi circulation, curing chills and alleviating pain”. Clinically, it is mainly used for the treatment of cardiovascular and cerebrovascular diseases. Ligustrazine (2,3,5,6-tetramethylpyrazine) is the main active ingredient of Ligusticum walliich. It was first isolated in 1962 .In recent years, studies have found that ligustrazine can inhibit the activity of the cerebral cortex and medullary respiratory center, excite vasomotors, induce the expansion of peripheral blood vessels, promote the blood flow of the coronary artery and lower limbs, and reduce blood pressure. Ligustrazine can also paralyze the nerve center and has sedative and analgesic effects.Studies have suggested that ligustrazine has a variety of new effects, including improving leptomeningeal and peripheral microcirculation and increasing cerebral blood flow, and its effect is better than that of papaverine. Ligustrazine can also protect against experimental cerebral ischemia and alleviate brain edema and the deposition of fibrin in microvessels. Ligustrazine is also used in the treatment of pulmonary heart disease, heart failure, dilated heart disease, portal hypertension, type II diabetes mellitus, tumor and coronary heart disease, and restenosis after stent implantation .

Definition

ChEBI: A member of the class of pyrazines that is pyrazine in which all four hydrogens have been replaced by methyl groups. An alkaloid extracted from Chuanxiong (Ligusticum wallichii).

Indications

Ligustrazine is used for occlusive vascular diseases, cerebral thrombosis, vasculitis, coronary heart disease, angina pectoris, and others

Aroma threshold values

Detection: 1 to 10 ppm. Aroma characteristics at 1.0%: slightly musty, nutty, cocoa-like with a vanilla undernote

Taste threshold values

Taste characteristics at 10 ppm: weak, nutty, musty cocoa and chocolate-like with dry coffee nuances.

General Description

2,3,5,6-Tetramethylpyrazine has been isolated from Ephedra sinica. It is useful in the treatment of several disorders such as asthma, heart failure, rhinitis and urinary incontinence. It is a flavor ingredient of tobacco. It forms cocrystal with 4-hydroxybenzoic acid which exhibits supramolecular synthon polymorphism.

Pharmacology

Traditional Chinese medicine has some advantages in comprehensive treatment under multisite, multitarget conditions and overall regulation. Ligustrazine can inhibit phosphodiesterase activity and inhibit platelet aggregation. It has the typical characteristics of a calcium antagonist and can adjust the release of various vasoactive substances against the vasoconstrictive action of the sympathetic nerve, improve microcirculation, reduce red blood cell aggregation, shorten the erythrocyte electrophoresis time, and thereby reduce blood viscosity .Ligustrazine can inhibit the proliferation of vascular endothelial cells induced by vascular endothelial growth factor, which may be one of the mechanisms by which angiogenesis is inhibited. The mechanism by which ligustrazine inhibits the proliferation of vascular endothelial cells may be through calcium ion retardation, inhibition of cell adhesion molecules, or through the antagonistic or synergistic effects of some growth factors involved in the proliferation and angiogenesis of vascular endothelial cellsStudies have shown that ligustrazine plays a role in resistance to ischemiareperfusion injury and antiapoptotic effects via the phosphatidylinositol 3- kinase/ protein kinase B (PI3K/Akt) pathway. The phosphorylation of endothelial nitric oxide synthase (eNOS) and generation of nitric oxide (NO) are important downstream effectors, which significantly enhance the myocardial protective effects of ligustrazine. one of the mechanisms of resistance to fibrosis .

Clinical Use

The main clinical formulation of ligustrazine is ligustrazine hydrochloride injection. Ligustrazine hydrochloride injection was used to prevent restenosis following coronary stent implantation and to treat acute coronary syndrome and ischemic stroke. Ligustrazine hydrochloride injection is helpful in alleviating pulmonary hypertension in patients with pulmonary heart disease. The therapeutic effect of ligustrazine hydrochloride injection on severe cholestatic liver cirrhosis caused by chronic heart failure of rheumatic heart disease is remarkable. In addition, ligustrazine is widely used in the treatment of vertigo syndrome, vertebrobasilar insufficiency, tension headache, and so on. It has a good symptomatic-treatment effect . Ligustrazine is also reported for the treatment of children with viral myocarditis, chronic renal failure, hepatic fibrosis, portal hypertension, tumors, and diabetic nephropathy. Ligustrazine can relieve symptoms rapidly, and its effect is stable and lasting. It has good clinical promotion value .

Safety Profile

Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion. When heated to decomposition it emits toxic fumes of NOx.

Check Digit Verification of cas no

The CAS Registry Mumber 1124-11-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,2 and 4 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1124-11:
(6*1)+(5*1)+(4*2)+(3*4)+(2*1)+(1*1)=34
34 % 10 = 4
So 1124-11-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H12N2/c1-5-6(2)10-8(4)7(3)9-5/h1-4H3

1124-11-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A18279)  2,3,5,6-Tetramethylpyrazine, 98+%   

  • 1124-11-4

  • 25g

  • 235.0CNY

  • Detail
  • Alfa Aesar

  • (A18279)  2,3,5,6-Tetramethylpyrazine, 98+%   

  • 1124-11-4

  • 100g

  • 804.0CNY

  • Detail
  • Vetec

  • (V900570)  2,3,5,6-Tetramethylpyrazine  Vetec reagent grade, 98%

  • 1124-11-4

  • V900570-25G

  • 373.23CNY

  • Detail
  • Aldrich

  • (183938)  2,3,5,6-Tetramethylpyrazine  98%

  • 1124-11-4

  • 183938-25G

  • 420.03CNY

  • Detail
  • Aldrich

  • (183938)  2,3,5,6-Tetramethylpyrazine  98%

  • 1124-11-4

  • 183938-100G

  • 2,036.97CNY

  • Detail

1124-11-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name Tetramethylpyrazine

1.2 Other means of identification

Product number -
Other names 2,3,5,6-tetramethylpyrazine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Food additives -> Flavoring Agents
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1124-11-4 SDS

1124-11-4Synthetic route

2,3,5,6-tetramethylpyrazine hydrochloride

2,3,5,6-tetramethylpyrazine hydrochloride

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
With sodium hydroxide In water96%
2,5-dichloro-3,6-dimethylpyrazine
27023-19-4

2,5-dichloro-3,6-dimethylpyrazine

trimethylaluminum
75-24-1

trimethylaluminum

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
With tetrakis(triphenylphosphine) palladium(0) In 1,4-dioxane; hexane for 4h; Heating;90%
3-amino-butan-2-one
52648-79-0

3-amino-butan-2-one

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
Stage #1: 3-amino-butan-2-one With acetic acid for 1.3h;
Stage #2: With potassium bromate; sodium hydrogensulfite Time;
87.2%
2.3-butanediol
513-85-9

2.3-butanediol

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
With carbonylchlorohydrido(4,5-bis((diisopropylphosphino)methyl)acridine)ruthenium(II); ammonia In toluene at 150℃; under 5250.53 Torr; for 36h; Inert atmosphere; Glovebox;85%
With aluminium oxide catalysts; ammonia at 400℃;
butane-2,3-dione mono-oxime
135636-66-7

butane-2,3-dione mono-oxime

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
With palladium on activated charcoal; ammonium formate In water at 80 - 90℃; for 4h; Solvent; Temperature;84.6%
With hydrogenchloride; tin Behandlung des entstandenen Methyl-<α-amino-aethyl>-ketons mit Alkalien;
With hydrogenchloride; tin(ll) chloride Behandlung des entstandenen Methyl-<α-amino-aethyl>-ketons mit Alkalien;
Tetramethylpyrazine hydrochloride

Tetramethylpyrazine hydrochloride

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
With sodium hydroxide In water76.1%
3-Amino-2-butanone hydrochloride
21419-24-9

3-Amino-2-butanone hydrochloride

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
With air; sodium acetate In methanol at 60℃;73%
ligustrazine hydrochloride

ligustrazine hydrochloride

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
With sodium hydroxide In water pH=3 - ~ 8;61.1%
diammonium hydrogenphosphate

diammonium hydrogenphosphate

3-hydroxy-2-butanon
513-86-0, 52217-02-4

3-hydroxy-2-butanon

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
In water55.5%
dimethylglyoxal
431-03-8

dimethylglyoxal

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
With hydrogenchloride; pyridoxal 5'-phosphate; (S)-1,2,3,4-tetrahydronapht-1-yl-amine; amine transaminase-113 In water; dimethyl sulfoxide at 30℃; for 72h; pH=7.4; Reagent/catalyst; Enzymatic reaction; chemoselective reaction;50%
acetonitrile
75-05-8

acetonitrile

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
With titanium tetrachloride; zinc In tetrahydrofuran for 144h; Heating;44%
With titanium tetrachloride; zinc In tetrahydrofuran for 144h; Heating; other nitriles;44%
pyridine
110-86-1

pyridine

L-Aspartic acid
56-84-8

L-Aspartic acid

acetic anhydride
108-24-7

acetic anhydride

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
und Einw. von Ammoniak;
2-acetamido-3-butanone
6628-81-5

2-acetamido-3-butanone

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
With hydrogenchloride Destillieren des Reaktionsprodukts mit Quecksilber(II)-chlorid und Kaliumcarbonat;
dimethyl glyoxime
17117-97-4

dimethyl glyoxime

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
With ethanol; nickel at 70 - 90℃; Hydrogenation;
3-chloro-2-butanone
4091-39-8

3-chloro-2-butanone

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
With ammonia
L-Aspartic acid
56-84-8

L-Aspartic acid

acetic anhydride
108-24-7

acetic anhydride

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
With pyridine Einw. von Ammoniak auf das Reaktionsprodukt;
N-methyl-2,5-dimethylpyrazinium bromide
88234-17-7

N-methyl-2,5-dimethylpyrazinium bromide

A

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

B

2,3,5-trimethylpyrazine
14667-55-1

2,3,5-trimethylpyrazine

Conditions
ConditionsYield
at 275 - 280℃;
butane-2,3-dione dioxime
95-45-4

butane-2,3-dione dioxime

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
With sodium hydroxide; zinc
2-<2-Hydroxy-2-(p-methylphenyl)ethyl>-3,5,6-trimethylpyrazine
72725-72-5

2-<2-Hydroxy-2-(p-methylphenyl)ethyl>-3,5,6-trimethylpyrazine

A

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

B

4-methyl-benzaldehyde
104-87-0

4-methyl-benzaldehyde

Conditions
ConditionsYield
In diethylene glycol dimethyl ether at 160℃; Kinetics; Thermodynamic data; other temperature (170 deg C) investigated; ΔH(excit.) and ΔS(excit.) given;
In various solvent(s) at 171.5℃; Kinetics; in diglyme-d14; isotopic effect;
2-<2-Hydroxy-2-(p-chlorophenyl)ethyl>-3,5,6-trimethylpyrazine
72725-77-0

2-<2-Hydroxy-2-(p-chlorophenyl)ethyl>-3,5,6-trimethylpyrazine

A

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

B

4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

Conditions
ConditionsYield
In diethylene glycol dimethyl ether at 160℃; Kinetics; Thermodynamic data; other temperature (170 deg C) and other solvent (DMF) investigated; ΔH(excit.) and ΔS(excit.) given;
2-<2-Hydroxy-2-(p-methoxyphenyl)ethyl>-3,5,6-trimethylpyrazine
72725-74-7

2-<2-Hydroxy-2-(p-methoxyphenyl)ethyl>-3,5,6-trimethylpyrazine

A

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

B

4-methoxy-benzaldehyde
123-11-5

4-methoxy-benzaldehyde

Conditions
ConditionsYield
In various solvent(s) at 171.5℃; Kinetics; in diglyme-d14; isotopic effect;
In diethylene glycol dimethyl ether at 160℃; Kinetics; Thermodynamic data; other temperature (170 deg C) and other solvent (DMF) investigated; ΔH(excit.) and ΔS(excit.) given;
2-<2-Hydroxy-2-ethyl>-3,5,6-trimethylpyrazine
72725-76-9

2-<2-Hydroxy-2-ethyl>-3,5,6-trimethylpyrazine

A

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

B

4-dimethylamino-benzaldehyde
100-10-7

4-dimethylamino-benzaldehyde

Conditions
ConditionsYield
In various solvent(s) at 171.5℃; Kinetics; in diglyme-d14; isotopic effect;
2-<2-Hydroxy-2-(p-nitrophenyl)ethyl>-3,5,6-trimethylpyrazine
72725-78-1

2-<2-Hydroxy-2-(p-nitrophenyl)ethyl>-3,5,6-trimethylpyrazine

A

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

B

4-nitrobenzaldehdye
555-16-8

4-nitrobenzaldehdye

Conditions
ConditionsYield
In diethylene glycol dimethyl ether at 160℃; Kinetics; Thermodynamic data; other temperature (170 deg C) investigated; ΔH(excit.) and ΔS(excit.) given;
2-(2-Hydroxy-2-phenylethyl)-3,5,6-trimethylpyrazine
10130-14-0

2-(2-Hydroxy-2-phenylethyl)-3,5,6-trimethylpyrazine

A

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

B

benzaldehyde
100-52-7

benzaldehyde

Conditions
ConditionsYield
In diethylene glycol dimethyl ether at 160℃; Kinetics; Thermodynamic data; other temperature (170 deg C) investigated; ΔH(excit.) and ΔS(excit.) given;
3-azido-butan-2-one
98022-59-4

3-azido-butan-2-one

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
With sodium hydrogen telluride 1.) ethanol; 2.) Celite; Yield given. Multistep reaction;
3-hydroxy-2-butanon
513-86-0, 52217-02-4

3-hydroxy-2-butanon

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

Conditions
ConditionsYield
With diammonium phosphate In water for 24h; Ambient temperature;42.6 % Chromat.
With ammonium acetate at 85℃; for 4h;
With ammonium acetate In water at 25℃; under 735.5 Torr; Rate constant; Thermodynamic data; Mechanism; Ea; other ammonium salts; var. solvents, temperature and pressure; effect of high pressure; effect of propylene glycol; effect of nicotinamide adenine dinucleotide and flavin adenine dinucleotide as hydrogen acceptors;
With sodium hydroxide; ammonium phosphate; ammonium citrate In water at 85℃; for 5h; phosphate buffer, pH 7.2; reaction in acetate buffer, pH 7.2; addition of MeOH and EtOH; effects of a buffer and solvent on tetramethylpyrazine formation in a 3-hydroxy-2-butanone-ammonium hydroxide system;
With ammonium acetate In water
3-hydroxy-2-butanon
513-86-0, 52217-02-4

3-hydroxy-2-butanon

A

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

B

2-(1-hydroxyethyl)-2,4,5-trimethyl-3-oxazoline

2-(1-hydroxyethyl)-2,4,5-trimethyl-3-oxazoline

Conditions
ConditionsYield
With diammonium phosphate In water for 24h; Product distribution; Mechanism; Ambient temperature; other acetols, other ammonia precursors, var. reaction time;A 5.6 % Chromat.
B 51.0 % Chromat.
With diammonium phosphate In water for 24h; Ambient temperature;A 5.6 % Chromat.
B 51.0 % Chromat.
3-hydroxy-2-butanon
513-86-0, 52217-02-4

3-hydroxy-2-butanon

A

2,4,5-trimethyloxazole
20662-84-4

2,4,5-trimethyloxazole

B

2,4,5-trimethyl-2,5-dihydro-1,3-oxazole
22694-96-8

2,4,5-trimethyl-2,5-dihydro-1,3-oxazole

C

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

D

2-(1-hydroxyethyl)-2,4,5-trimethyl-3-oxazoline

2-(1-hydroxyethyl)-2,4,5-trimethyl-3-oxazoline

E

(E)-5-Hydroxy-3,4-dimethyl-hex-3-en-2-one

(E)-5-Hydroxy-3,4-dimethyl-hex-3-en-2-one

F

3-[2-Hydroxy-1-methyl-prop-(E)-ylideneamino]-butan-2-one

3-[2-Hydroxy-1-methyl-prop-(E)-ylideneamino]-butan-2-one

Conditions
ConditionsYield
With ammonium acetate In water at 25℃; Rate constant; Thermodynamic data; Mechanism; E(a); other solvents, var. temp.;
3-hydroxy-2-butanon
513-86-0, 52217-02-4

3-hydroxy-2-butanon

A

2,4,5-trimethylthiazole
13623-11-5

2,4,5-trimethylthiazole

B

Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

C

2-(1-mercaptoethyl)-2,4,5-trimethyl-3-thiazoline
84310-28-1

2-(1-mercaptoethyl)-2,4,5-trimethyl-3-thiazoline

D

2-(1-hydroxyethyl)-2,4,5-trimethyl-3-oxazoline

2-(1-hydroxyethyl)-2,4,5-trimethyl-3-oxazoline

E

2-(1-mercaptoethyl)-2,4,5-trimethyl-3-oxazoline

2-(1-mercaptoethyl)-2,4,5-trimethyl-3-oxazoline

F

2-(1-hydroxyethyl)-2,4,5-trimethyl-3-thiazoline

2-(1-hydroxyethyl)-2,4,5-trimethyl-3-thiazoline

Conditions
ConditionsYield
With hydrogenchloride; ammonium sulfide at 50℃; for 2h; Product distribution; var. temp.;
Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

cyclobis[[cis-Pt(R(-)-DIPO)(4-ethynylpyridine)2][cis-Pt(R(+)-BINAP)(CF3SO3)2]]*2AgCF3SO3*4H2O

cyclobis[[cis-Pt(R(-)-DIPO)(4-ethynylpyridine)2][cis-Pt(R(+)-BINAP)(CF3SO3)2]]*2AgCF3SO3*4H2O

cyclobis[[cis-Pt(R(-)-DIOP)(4-ethynylpyridine)2][cis-Pt(R(+)-BINAP)(OSO2CF3)2]]*2AgOTf*tetramethylpyrazine*4H2O

cyclobis[[cis-Pt(R(-)-DIOP)(4-ethynylpyridine)2][cis-Pt(R(+)-BINAP)(OSO2CF3)2]]*2AgOTf*tetramethylpyrazine*4H2O

Conditions
ConditionsYield
In dichloromethane-d2 shaking (25°C); solvent removal (N2, vac.); elem. anal.;100%
Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

cycylobis[[cis-Pt(S(+)-DIOP)(4-ethynylpyridine)2][cis-Pd(R(+)-BINAP)(OSO2CF3)2]]*2AgOTf*4H2O

cycylobis[[cis-Pt(S(+)-DIOP)(4-ethynylpyridine)2][cis-Pd(R(+)-BINAP)(OSO2CF3)2]]*2AgOTf*4H2O

cyclobis[[cis-Pt(S(+)-DIOP)(4-ethynylpyridine)2][cis-Pd(R(+)-BINAP)(OSO2CF3)2]]*2AgOTf*tetramethylpyrazine*4H2O

cyclobis[[cis-Pt(S(+)-DIOP)(4-ethynylpyridine)2][cis-Pd(R(+)-BINAP)(OSO2CF3)2]]*2AgOTf*tetramethylpyrazine*4H2O

Conditions
ConditionsYield
In dichloromethane-d2 shaking (25°C); solvent removal (N2, vac.); elem. anal.;100%
Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

carbon dioxide
124-38-9

carbon dioxide

3,5,6-trimethyl-2-pyrazinylacetic acid lithium salt
107209-20-1

3,5,6-trimethyl-2-pyrazinylacetic acid lithium salt

Conditions
ConditionsYield
With lithium diisopropyl amide In hexane 1) hexane, 0 deg C, 30 min, 2) 0 deg C, 30 min;99%
Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

cyclobis[[cis-Pt(R(+)-DIOP)(4-ethynylpyridine)2][cis-Pd(PEt3)2-(OSO2CF3)2]]*2AgOTf

cyclobis[[cis-Pt(R(+)-DIOP)(4-ethynylpyridine)2][cis-Pd(PEt3)2-(OSO2CF3)2]]*2AgOTf

cycylobis[[cis-Pt(R(+)-DIOP)(4-ethynylpyridine)2][cis-Pd(PEt3)2(OSO2CF3)2]]*2AgOTf*tetramethylpyrazine*3H2O

cycylobis[[cis-Pt(R(+)-DIOP)(4-ethynylpyridine)2][cis-Pd(PEt3)2(OSO2CF3)2]]*2AgOTf*tetramethylpyrazine*3H2O

Conditions
ConditionsYield
In acetone shaking (room temp., 5 min), NMR monitoring; solvent removal (dry N2), drying (vac.); elem. anal.;99%
Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

dichloro-bis(triethylphosphine)-di-μ-chloro-diplatinum(II)

dichloro-bis(triethylphosphine)-di-μ-chloro-diplatinum(II)

trans-{PtCl2(triethylphosphine)}2(2,3,5,6-tetamethylpyrazine)
118515-87-0

trans-{PtCl2(triethylphosphine)}2(2,3,5,6-tetamethylpyrazine)

Conditions
ConditionsYield
In chloroform-d1 ligand and Pt complex (1:2 mol) in CDCl3 (or CD2Cl2) were stirred for 5 min; floating layer of hexane over soln.; elem. anal.;94%
Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

2-(bromomethyl)-3,5,6-trimethylpyrazine
79074-45-6

2-(bromomethyl)-3,5,6-trimethylpyrazine

Conditions
ConditionsYield
With N-Bromosuccinimide; dibenzoyl peroxide In tetrachloromethane at 30℃; Reflux;92%
With N-Bromosuccinimide; dibenzoyl peroxide In tetrachloromethane75%
With N-Bromosuccinimide; dibenzoyl peroxide In tetrachloromethane at 75℃; for 10h; Incandescent irradiation;72.8%
Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

{Pt2Cl2(μ-Cl)2(PMePh2)2}
16633-87-7

{Pt2Cl2(μ-Cl)2(PMePh2)2}

trans-{PtCl2(diphenylmethylphosphine)}2(2,3,5,6-tetramethylpyrazine)
118515-91-6

trans-{PtCl2(diphenylmethylphosphine)}2(2,3,5,6-tetramethylpyrazine)

Conditions
ConditionsYield
In chloroform-d1 ligand and Pt complex (1:2 mol) in CDCl3 (or CD2Cl2) were stirred for 5 min; floating layer of hexane over soln.; elem. anal.;91%
Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

4-(hexyloxy)benzaldehyde
5736-94-7

4-(hexyloxy)benzaldehyde

(E,E,E,E)-2,3,5,6-tetrakis[2-(4-hexyloxyphenyl)ethenyl]pyrazine

(E,E,E,E)-2,3,5,6-tetrakis[2-(4-hexyloxyphenyl)ethenyl]pyrazine

Conditions
ConditionsYield
With potassium tert-butylate In N,N-dimethyl-formamide at 23℃; for 4h; Inert atmosphere;91%
Multi-step reaction with 2 steps
1: potassium tert-butylate / N,N-dimethyl-formamide
2: potassium tert-butylate / N,N-dimethyl-formamide
View Scheme
Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

acetylferrocene
1271-55-2

acetylferrocene

C20H22FeN2

C20H22FeN2

Conditions
ConditionsYield
Stage #1: Tetramethylpyrazine With n-butyllithium In tetrahydrofuran; hexane at -25 - 20℃; Inert atmosphere;
Stage #2: acetylferrocene With acetic anhydride; acetic acid In tetrahydrofuran; hexane at 120℃; for 2h; Inert atmosphere;
90%
Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

2,3,5,6-tetramethylpyrazine mono N-oxide
22978-83-2

2,3,5,6-tetramethylpyrazine mono N-oxide

Conditions
ConditionsYield
With dihydrogen peroxide; acetic acid at 70℃;88.2%
With dihydrogen peroxide; acetic acid at 0 - 60℃;82%
With dihydrogen peroxide; acetic acid at 94℃; for 12h;78.8%
Tetramethylpyrazine
1124-11-4

Tetramethylpyrazine

4-hydroxyisophthalic acid
636-46-4

4-hydroxyisophthalic acid

2C8H6O5*C8H12N2

2C8H6O5*C8H12N2

Conditions
ConditionsYield
In methanol at 20℃; for 336h;88%

1124-11-4Related news

Tetramethylpyrazine (cas 1124-11-4) ameliorates experimental autoimmune encephalomyelitis by modulating the inflammatory response09/29/2019

Multiple sclerosis (MS) is a disabling inflammatory and demyelinating disorder of the central nervous system. Tetramethylpyrazine (TMP) has been demonstrated to ameliorate cerebral ischemic injury and spinal cord injury by inhibiting inflammatory cell activation and pro-inflammatory cytokine pro...detailed

Neuropharmacology and analgesiaProtective effects of Tetramethylpyrazine (cas 1124-11-4) analogue Z-11 on cerebral ischemia reperfusion injury09/28/2019

The aim of our study was to investigate the effects of a new synthetic compound (E) -1- (E) -1- (2- hydroxy -5- chlorophenyl) -3- (3, 5, 6- three methyl pyrazine -2- based) -2- propylene -1 ketone, Z-11, a tetramethylpyrazine analogue, on cerebral ischemia reperfusion injury and the underlying m...detailed

Effects of Tetramethylpyrazine (cas 1124-11-4) from Chinese black vinegar on antioxidant and hypolipidemia activities in HepG2 cells10/01/2019

Tetramethylpyrazine is a bioactive compound found in Chinese black vinegar. This work is to investigate the potential effects of tetramethylpyrazine on intracellular cholesterol modulation in HepG2 cells. The results demonstrated that tetramethylpyrazine can induce intracellular cholesterol effl...detailed

GC–FID determination of Tetramethylpyrazine (cas 1124-11-4) and acetoin in vinegars and quantifying the dependence of Tetramethylpyrazine (cas 1124-11-4) on acetoin and ammonium09/27/2019

2,3,5,6-Tetramethylpyrazine (TMP) is an important health functional composition in vinegars, but there are controversial viewpoints about its formation mechanism and scarce relevant records on TMP content enhancement in vinegar products. In this study, a simple and accurate solvent extraction co...detailed

Thermodynamics, molecular modelling and denaturation studies on exploring the binding mechanism of Tetramethylpyrazine (cas 1124-11-4) with human serum albumin09/26/2019

Tetramethylpyrazine (TMPZ), a Chinese herb effectively used for cardiovascular disorders. The present study reports in vitro interaction studies of TMPZ with human serum albumin (HSA) using various spectroscopic, isothermal titration calorimetric (ITC), molecular modelling studies. The associati...detailed

Analytical MethodsDispersive liquid–liquid microextraction for rapid and inexpensive determination of Tetramethylpyrazine (cas 1124-11-4) in vinegar09/25/2019

The concentration of tetramethylpyrazine (TMP) in vinegar is an active indicator of vinegar quality. Dispersive liquid–liquid microextraction (DLLME) was first applied to vinegar as a clean-up pre-treatment for the rapid (5 min) determination of TMP by high-pressure liquid chromatography with u...detailed

High yield of Tetramethylpyrazine (cas 1124-11-4) in functional Fuqu using bacillus amyloliquefaciens09/24/2019

Fuqu is an important starter culture used for Chinese liquor brewing. And distillers’ grains (DGS) are the main by-product of the Chinese liquor industry. Tetramethylpyrazine (TTMP) is an important functional substance and key characteristic aroma component in Chinese liquor. A strain with high...detailed

1124-11-4Relevant articles and documents

-

Zavyalov,Ezhova

, (1979)

-

Kanatomi,H.,Murase,I.

, p. 226 - 231 (1970)

Formation of 2-(1-Hydroxyalkyl)-3-oxazolines from the Reaction of Acyloins and Ammonia Precursors under Mild Conditions

Shu, Chi-Kuen,Lawrence, Brian M.

, p. 2922 - 2924 (1995)

Studies on the reaction between acetoin and an ammonia precursor under mild conditions revealed that two major products were formed, one of which was tetramethylpyrazine (TMP) and the other an unknown compound.By spectral elucidation (MS, IR, NMR), this unknown compound has been identified as 2,4,5-trimethyl-2-(1-hydroxyethyl)-3-oxazoline (OXZ).Two homologs of OXZ were also prepared.A 3-week storage study demonstrated that OXZ was readily formed, after which its formation declined.In contrast, TMP formation gradually increased before it leveled out in 15-20 days.At the end of this experiment, only TMP remained as the product, while OXZ was not found.Mechanistically, it is proposed that condensation of acetoin and ammonia generates α-hydroxyimine or α-amino ketone by tautomerism, which may lead to product formation via two pathways.One of the pathways is to form TMP via self-condensation of the α-amino ketone, dehydration, and dehydrogenation, which is well-known.The other pathway may be that the α-hydroxyimine condenses with a second molecule of acetoin and then is cyclized by Schiff base formation to OXZ.These storage results also indicate that the second pathway may be reversible, so that OXZ initially formed is able to be converted back to α-hydroxyimine, which, in turn, was tautomerized to α-amino ketone, so that the first pathway to form TMP could be followed. - Keywords: Acyloins; ammonia precursor; 2-(1-hydroxyalkyl)-3-oxazolines; 2,4,5-trimethyl-2-(1-hydroxyethyl)-3-oxazoline; 2,4-dimethyl-2-(hydroxymethyl)-3-oxazoline; 2,4,5-triethyl-2-(1-hydroxypropyl)-3-oxazoline; acetoin; acetol; 4-hydroxy-3-hexanone; diammonium hydrogen phosphate

Mechanistic Studies of Tetramethylpyrazine Formation under Weak Acidic Conditions and High Hydrostatic Pressure

Huang, Tzou-Chi,Fu, Hui-Yin,Ho, Chi-Tang

, p. 240 - 246 (1996)

A significant enhancement of the tetramethylpyrazine (TMP) formation at high pressure was observed in the 3-hydroxy-2-butanone/ammonium acetate model system. In a water system, the activation volume of TMP formation under high pressure was found to be -6.82 mL/mol. A mechanism was proposed to elucidate the formation of TMP under a weak acidic condition and high hydrostatic pressure. Solvents such as propylene glycol (PG), glycerol, methanol, ethanol, propanol, and butanol were found to enhance TMP formation. Kinetic analyses indicated that TMP formation in aqueous, 80% PG, and ethanol systems followed pseudo-zero-order reaction kinetics. The activation energies were found to be 18.84 ± 1.3, 14.19 ± 7.1, and 13.09 ± 4.7 kcal/mol, respectively. The intermediate of TMP formation was characterized as tetramethyldihdyropyrazine using gas chromatography-mass spectrometry. A 15N-labeled ammonium acetate/3-hydroxy-2-butanone model system was used to confirm the incorporation of a nitrogen atom in the molecule of tetramethyldihydropyrazine. Hydrogen acceptors such as nicotinamide adenine dinucleotide and flavin adenine dinucleotide were found to increase TMP formation, and the formation of TMP from tetramethyldihydropyrazine through dehydrogenation was shown.

Characterization of volatile compounds from the reaction of 3-hydroxy- 2-butanone and ammonium sulfide model system

Xi, Junwu,Huang, Tzou-Chi,Ho, Chi-Tang

, p. 245 - 248 (1999)

The reactions between 3-hydroxy-2-butanone and ammoniun sulfide at 25, 50, 75, 100, 125, and 150 °C were studied. Four well-known flavor compounds, 2,4,5-trimethyloxazole, 2,4,5-trimethyl-3-oxazoline, 2,4,5-trimethylthiazole, and 2,4,5-trimethyl-3-thiazoline, were identified. Another four interesting intermediate compounds, 2-(1-hydroxyethyl)-2,4,5-trimethyl-3-oxazoline, 2- (1-mercaptoethyl)-2,4,5-trimethyl-3-oxazoline, 2-(1-hydroxyethyl)-2,4,5- trimethyl-3-thiazoline, and 2-(1-mercaptoethyl)-2,4,5-trimethyl-3-thiazoline, were also identified by GC-EIMS and GC-CIMS. All these intermediate compounds were formed at 25 °C. On the other hand, tetramethylpyrazine was the major product with a reaction temperature higher than 100 °C.

Acceptorless Dehydrogenative Coupling Using Ammonia: Direct Synthesis of N-Heteroaromatics from Diols Catalyzed by Ruthenium

Daw, Prosenjit,Ben-David, Yehoshoa,Milstein, David

supporting information, p. 11931 - 11934 (2018/09/27)

The synthesis of N-heteroaromatic compounds via an acceptorless dehydrogenative coupling process involving direct use of ammonia as the nitrogen source was explored. We report the synthesis of pyrazine derivatives from 1,2-diols and the synthesis of N-substituted pyrroles by a multicomponent dehydrogenative coupling of 1,4-diols and primary alcohols with ammonia. The acridine-based Ru-pincer complex 1 is an effective catalyst for these transformations, in which the acridine backbone is converted to an anionic dearomatized PNP-pincer ligand framework.

A four-methyl pyrazine preparation method (by machine translation)

-

Paragraph 0021; 0027; 0028; 0029; 0030; 0031; 0032, (2017/07/01)

The invention relates to a medicine intermediate four methyl pyrazine synthesis method, the method comprising: in order to diacetyl monoxime as raw materials, the addition of water as the solvent, palladium carbon as a catalyst, in backflow state by adding ammonium formate, after adding continue to stir at reflux 4 hours, filtering to remove the catalyst, the temperature and then the methylene chloride extraction, pressure reducing and concentrated to obtain four a [...]. The invention production four-methyl pyrazine mild reaction conditions, easy post treatment, the conversion is 95% or more, the yield is 80% or more, and the cost is low, and is favorable for industrial production. (by machine translation)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1124-11-4